These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4131488)

  • 1. Results and therapeutic consequences of general resistance tests in tuberculosis of the urogenital system (author's transl).
    Gabler A
    Med Klin; 1973 Dec; 68(50):4648-52. PubMed ID: 4131488
    [No Abstract]   [Full Text] [Related]  

  • 2. [Modern view points on the therapy of urogenital tuberculosis].
    Wehrheim W
    Z Urol Nephrol; 1973 Aug; 66(8):627-30. PubMed ID: 4129653
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experiences with new tuberculostatics in the treatment of urogenital tuberculosis (capreomycin, ethambutol, rifampicin)].
    May P; König K
    Z Urol Nephrol; 1969; 62(9):657-62. PubMed ID: 5408556
    [No Abstract]   [Full Text] [Related]  

  • 4. Resistance pattern of Mycobacterium tuberculosis and Mycobacterium bovis to ethambutol.
    Tsukamura M
    Acta Tuberc Pneumol Scand; 1965; 46(2):88-92. PubMed ID: 4964850
    [No Abstract]   [Full Text] [Related]  

  • 5. [Activity of the second-line preparations, ethambutol and rifampin, in experimental tuberculosis caused by Mycobacterium tuberculosis highly resistant to basic tuberculostatics].
    Golyshevskaia VI; El'shanskaia MP
    Probl Tuberk; 1973; 51(12):60-4. PubMed ID: 4205666
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of rifampicin and ethambutol on Mycobacterium tuberculosis in vitro].
    Bialik IB; Klimenko MT
    Probl Tuberk; 1973; 51(2):56-61. PubMed ID: 4203996
    [No Abstract]   [Full Text] [Related]  

  • 7. A study of primary drug resistance in pulmonary tuberculosis in west Malaysia 1984-1987.
    Jalleh RD; Kuppusamy I; Soshila R; Aziah AM; Faridza MY
    Med J Malaysia; 1993 Jun; 48(2):113-6. PubMed ID: 8350784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A study on the tubercle bacillus drug-resistance test for RFP, EB, 1321 Th and KM (author's transl)].
    Xiao XL
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1981 Aug; 4(4):224-5. PubMed ID: 6804194
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies of the criteria of chemoresistance to rifampicin and ethambutol].
    Bogdănescu V; Negulescu E; Ticău S; Vlădescu D
    Ftiziologia; 1973; 22(6):611-21. PubMed ID: 4204427
    [No Abstract]   [Full Text] [Related]  

  • 10. [Characteristics of the mycobacteria isolated from urogenital tuberculosis patients].
    Blagodarnyĭ IaA; Bekmagambetova ZhZh; Krivtsova AE; Sidorkina EV; Blonskaia LI
    Probl Tuberk; 1979 Sep; (9):61-5. PubMed ID: 116222
    [No Abstract]   [Full Text] [Related]  

  • 11. [Criteria of resistance of some antibiotics and chemotherapeutics for strains of Mycobacterium tuberculosis isolated in Czechoslovakia. Cycloserin, ethionamide, pyrazinamide, rifampicin, and ethambutol (author's transl)].
    Víznerová A
    Cas Lek Cesk; 1979 Feb; 118(8):240-5. PubMed ID: 109213
    [No Abstract]   [Full Text] [Related]  

  • 12. Investigation into the relationship of M ulcerans to M. buruli and other mycobacteria.
    Schröder KH
    Am Rev Respir Dis; 1975 Apr; 111(4):559-62. PubMed ID: 47730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myambutol: chemistry, pharmacology, and toxicology.
    Kanther R
    Antibiot Chemother; 1970; 16():203-14. PubMed ID: 5002301
    [No Abstract]   [Full Text] [Related]  

  • 14. The "in vitro" activity of rifampicin compared with ethambutol, capreomycin and isoniazid.
    Steinbrück PW
    Acta Tuberc Pneumol Belg; 1969; 60(3):413-6. PubMed ID: 4984421
    [No Abstract]   [Full Text] [Related]  

  • 15. [Distribution of variants resistant to ethambutol or to capreomycine in wild strains of Mycobacterium tuberculosis].
    Arima J; Igarashi H
    C R Seances Soc Biol Fil; 1972 Nov; 166(2):474-6. PubMed ID: 4122644
    [No Abstract]   [Full Text] [Related]  

  • 16. [Determination of resistance of Mycobacterium tuberculosis against isonicotinic acid hydrazide, streptomycin, para-aminosalicylic acid, ethionamide, ethambutol and rifampicin using the 32 P incorporation test].
    Reutgen H
    Acta Biol Med Ger; 1973; 30(3):309-16. PubMed ID: 4202698
    [No Abstract]   [Full Text] [Related]  

  • 17. Rifampicin and ethambutol in the treatment of drug resistant and far advanced pulmonary tuberculosis (with a note on capreomycin).
    Pines A; Raafat H; Siddiqui GM
    J Ir Med Assoc; 1970 Mar; 63(393):82-5. PubMed ID: 4984340
    [No Abstract]   [Full Text] [Related]  

  • 18. [Critical concentration for definition of rifampicin resistance of tubercle bacilli].
    Tsukamura M
    Kekkaku; 1972 May; 47(5):113-9. PubMed ID: 4625369
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on the antituberculous activities of rifampicin (REP) and the period of exposure in vitro (author's transl)].
    Uratsuji Y
    Bull Chest Dis Res Inst Kyoto Univ; 1978 Mar; 10(1-2):1-19. PubMed ID: 99200
    [No Abstract]   [Full Text] [Related]  

  • 20. [Criteria of clinical resistance of cycloserine, ethionamide and ethambutol].
    Okamoto K; Watanabe S; Terunuma K
    Kekkaku; 1970 Feb; 45(2):65-72. PubMed ID: 4985702
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.